Challenge Roth July 6, 2026
Metabolics obesity drug - phase 2B clinical trial results: trial results do not support commercial viability of obesity project: programme is terminated [ASX Announcement]
Adapting your exercise and physical activity routine post-gallbladder removal is a step-by-step process
Medical News Today A new study investigated why different obesity treatments, including diets, surgeries and new medications like GLP-1 receptor agonists, such as semaglutide and tirzepatide, lead to varying times at which weight loss plateaus
If you are taking any blood-thinner medication, avoid consuming turmeric and other blood-thinning foods
66 Disease refractory to antimalarials can be treated with immunosuppressives common in the rheumatologists armamentarium, including methotrexate (MTX), mycophenolate mofetil (MMF), or azathioprine (AZA), although AZA is frequently less effective